LifeVantage Corporation Q4 2026 Earnings Recap

LifeVantage shares fell 1.5% after earnings. Revenue declined 23.1%, while the new CEO said the company would not provide formal guidance as he assesses the business and develops a growth strategy, leaving the near-term outlook unclear.

Key Takeaways

• Fiscal Q4 revenue was $42.4 million, down 23.1% from $55.1 million a year earlier.
• Management attributed the decline to fewer orders from active accounts and lower average order size, citing macroeconomic pressure and lower MindBody GLP-1 System sales against a higher year-ago comparison; LoveBiome sales partially offset the decline.
• CEO Terrence Moorehead, who joined only a few weeks ago, identified brand positioning, the consumer proposition, and operational excellence and profitability as early priorities.
• Moorehead said LifeVantage would not provide formal guidance while management assesses the business and develops a growth strategy.
• The CEO cited historically near-80% gross margins as an opportunity, but the call excerpt provided no updated margin results.